FWM
ANGO icon

Filbrandt Wealth Management’s AngioDynamics ANGO Stock Holding History

Filbrandt Wealth Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-60
Closed -$1K – 366
2020
Q1 		$1K Buy
+60
New +$753 ﹤0.01% 194

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Filbrandt Wealth Management's ANGO Position: Q2 2020 in Review

Filbrandt Wealth Management sold out of AngioDynamics (ANGO) in Q2 2020, closing a stake of 60 shares — an estimated $1K sold.

Filbrandt Wealth Management first reported a position in ANGO in Q1 2020 and held it in 1 quarter. The position peaked at $1K in Q1 2020. 146 funds tracked by Wall St. Rank hold ANGO as of Q2 2020.

  • Filbrandt Wealth Management reported no remaining AngioDynamics position as of Q2 2020 after selling out during the quarter.
  • Filbrandt Wealth Management sold 60 AngioDynamics shares in Q2 2020, an estimated $1K.
  • Filbrandt Wealth Management first reported a position in AngioDynamics in Q1 2020 and held it in 1 quarter.
  • Filbrandt Wealth Management's AngioDynamics position peaked at $1K in Q1 2020.
  • 146 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2020.

Based on Filbrandt Wealth Management's 13F filing for Q2 2020, filed 11 Aug 2020.